Martin Linhult, Susanne Gülich, Torbjörn Gräslund, Per-Ake Nygren, Sophia Hober
{"title":"Evaluation of different linker regions for multimerization and coupling chemistry for immobilization of a proteinaceous affinity ligand.","authors":"Martin Linhult, Susanne Gülich, Torbjörn Gräslund, Per-Ake Nygren, Sophia Hober","doi":"10.1093/protein/gzg121","DOIUrl":null,"url":null,"abstract":"<p><p>Alkaline conditions are generally preferred for sanitization of chromatography media by cleaning-in-place (CIP) protocols in industrial biopharmaceutical processes. The use of such rigorous conditions places stringent demands on the stability of ligands intended for use in affinity chromatography. Here, we describe efforts to meet these requirements for a divalent proteinaceous human serum albumin (HSA) binding ligand, denoted ABD*dimer. The ABD*dimer ligand was constructed by genetic head-to-tail linkage of two copies of the ABD* moiety, which is a monovalent and alkali-stabilized variant of one of the serum albumin-binding motifs of streptococcal protein G. Dimerization was performed to investigate whether a higher HSA-binding capacity could be obtained by ligand multimerization. We also investigated the influence on alkaline stability and HSA-binding capacity of three variants (VDANS, VDADS and GGGSG) of the inter-domain linker. Biosensor binding studies showed that divalent ligands coupled using non-directed chemistry demonstrate an increased molar HSA-binding capacity compared with monovalent ligands. In contrast, equal molar binding capacities were observed for both types of ligands when using directed ligand coupling chemistry involving the introduction and recruitment of a unique C-terminal cysteine residue. Significantly higher molar binding capacities were also detected when using the directed coupling chemistry. These results were confirmed in affinity chromatography binding capacity experiments, using resins containing thiol-coupled ligands. Interestingly, column sanitization studies involving exposure to 0.1 M NaOH solution (pH 13) showed that of all the tested constructs, including the monovalent ligand, the divalent ligand construct containing the VDADS linker sequence was the most stable, retaining 95% of its binding capacity after 7 h of alkaline treatment.</p>","PeriodicalId":20902,"journal":{"name":"Protein engineering","volume":"16 12","pages":"1147-52"},"PeriodicalIF":0.0000,"publicationDate":"2003-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/protein/gzg121","citationCount":"15","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Protein engineering","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/protein/gzg121","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 15
Abstract
Alkaline conditions are generally preferred for sanitization of chromatography media by cleaning-in-place (CIP) protocols in industrial biopharmaceutical processes. The use of such rigorous conditions places stringent demands on the stability of ligands intended for use in affinity chromatography. Here, we describe efforts to meet these requirements for a divalent proteinaceous human serum albumin (HSA) binding ligand, denoted ABD*dimer. The ABD*dimer ligand was constructed by genetic head-to-tail linkage of two copies of the ABD* moiety, which is a monovalent and alkali-stabilized variant of one of the serum albumin-binding motifs of streptococcal protein G. Dimerization was performed to investigate whether a higher HSA-binding capacity could be obtained by ligand multimerization. We also investigated the influence on alkaline stability and HSA-binding capacity of three variants (VDANS, VDADS and GGGSG) of the inter-domain linker. Biosensor binding studies showed that divalent ligands coupled using non-directed chemistry demonstrate an increased molar HSA-binding capacity compared with monovalent ligands. In contrast, equal molar binding capacities were observed for both types of ligands when using directed ligand coupling chemistry involving the introduction and recruitment of a unique C-terminal cysteine residue. Significantly higher molar binding capacities were also detected when using the directed coupling chemistry. These results were confirmed in affinity chromatography binding capacity experiments, using resins containing thiol-coupled ligands. Interestingly, column sanitization studies involving exposure to 0.1 M NaOH solution (pH 13) showed that of all the tested constructs, including the monovalent ligand, the divalent ligand construct containing the VDADS linker sequence was the most stable, retaining 95% of its binding capacity after 7 h of alkaline treatment.
在工业生物制药过程中,通过就地清洗(CIP)协议对色谱介质的消毒通常首选碱性条件。在这种严格的条件下,对亲和色谱中使用的配体的稳定性提出了严格的要求。在这里,我们描述了满足这些要求的二价蛋白性人血清白蛋白(HSA)结合配体的努力,称为ABD*二聚体。ABD*二聚体配体是链球菌蛋白g的一种血清白蛋白结合基序的单价和碱稳定变体,通过遗传头尾连锁构建ABD*二聚体配体,以研究是否可以通过配体聚合获得更高的hsa结合能力。我们还研究了三种结构域间连接体变体(VDANS、VDADS和GGGSG)对碱性稳定性和hsa结合能力的影响。生物传感器结合研究表明,与单价配体相比,使用非定向化学偶联的二价配体表现出更高的hsa摩尔结合能力。相反,当使用定向配体偶联化学涉及引入和招募独特的c端半胱氨酸残基时,观察到两种类型的配体的摩尔结合能力相等。当使用定向偶联化学时,还检测到显着更高的摩尔结合能力。这些结果在含有巯基偶联配体的树脂的亲和色谱结合能力实验中得到了证实。有趣的是,暴露于0.1 M NaOH溶液(pH 13)的柱消毒研究表明,在包括单价配体在内的所有测试结构中,含有VDADS连接体序列的二价配体结构最稳定,在碱性处理7小时后保留了95%的结合能力。